Melanoma (Skin) Cancer, Stage of Disease at Diagnosis by Year, Delta vs. Non-Delta Regions, 2003-2011
2003^
Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 30.6% 29.4%
Localized 55.1% 52.9%
Regional 6.1% 5.9%
Distant 0.0% 2.9%
Unknown 8.2% 8.8%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 33.9% 25.0%
Localized 50.2% 61.4%
Regional 4.5% 6.5%
Distant 4.1% 2.7%
Unknown 7.2% 4.3%
2004
Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 30.2% 25.9%
Localized 39.5% 63.0%
Regional 7.0% 3.7%
Distant 9.3% 3.7%
Unknown 14.0% 3.7%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 36.0% 24.0%
Localized 45.7% 58.3%
Regional 9.7% 6.9%
Distant 4.0% 4.4%
Unknown 4.7% 6.4%
2005
Delta region
Stage at
Diagnosis
White Males White Females
In Situ 38.6% 31.7%
Localized 45.5% 58.5%
Regional 4.5% 2.4%
Distant 9.1% 0.0%
Unknown 2.3% 7.3%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 28.8% 26.2%
Localized 54.2% 63.4%
Regional 6.7% 4.9%
Distant 5.1% 2.7%
Unknown 5.1% 2.7%
2006
Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 44.0% 26.9%
Localized 40.0% 50.0%
Regional 8.0% 19.2%
Distant 6.0% 3.8%
Unknown 2.0% 0.0%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 40.4% 33.8%
Localized 50.4% 57.5%
Regional 2.2% 5.3%
Distant 5.0% 1.3%
Unknown 1.9% 2.2%
2007
Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 36.4% 48.1%
Localized 45.5% 44.4%
Regional 13.6% 0.0%
Distant 4.5% 7.4%
Unknown 0.0% 0.0%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 39.6% 32.8%
Localized 48.6% 57.8%
Regional 7.1% 3.5%
Distant 3.3% 3.1%
Unknown 1.4% 2.7%
2008
Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 35.5% 32.4%
Localized 45.2% 52.9%
Regional 11.3% 8.8%
Distant 0.0% 2.9%
Unknown 8.1% 2.9%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 41.0% 32.0%
Localized 47.6% 57.8%
Regional 5.4% 5.1%
Distant 3.4% 2.5%
Unknown 2.7% 2.5%
2009
Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 42.5% 26.9%
Localized 37.5% 53.8%
Regional 5.0% 11.5%
Distant 7.5% 7.7%
Unknown 7.5% 0.0%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 40.0% 33.1%
Localized 49.5% 59.5%
Regional 5.8% 3.7%
Distant 2.8% 2.0%
Unknown 1.9% 1.7%
2010
Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 35.8% 31.3%
Localized 54.7% 56.3%
Regional 3.8% 6.3%
Distant 3.8% 3.1%
Unknown 1.9% 3.1%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 41.6% 35.5%
Localized 48.6% 57.4%
Regional 5.6% 4.2%
Distant 2.8% 1.5%
Unknown 1.3% 1.5%
2011
Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 45.2% 27.0%
Localized 40.5% 67.6%
Regional 2.4% 5.4%
Distant 9.5% 0.0%
Unknown 2.4% 0.0%
Non-Delta Region
Stage at
Diagnosis
White Males White Females
In Situ 36.7% 37.2%
Localized 52.6% 50.8%
Regional 6.0% 7.1%
Distant 3.6% 2.5%
Unknown 1.0% 2.5%
^Use caution when comparing 2003 data to later years.  The staging system changed between 2003 and 2004.
These data were collected by the Mississippi Cancer Registry which participates in the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC).  These data were generated and posted on 04/02/2014.